Patent intelligence · US
US 12005220
Microneedle patch for immunostimulatory drug delivery
Microneedle patch for immunostimulatory drug delivery
Patent details — US 12005220
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 11, 2024
- Expiration
- Jun 6, 2044
- Applicant
- Veradermics Incorporated
- Claims
- 30
- CPC classes
- A61K, A61K2039/55555, A61K39/0002, A61K39/12
Quick answer
US 12005220 (Microneedle patch for immunostimulatory drug delivery) is held by Veradermics Incorporated. Status: granted. Granted Jun 11, 2024. Expires Jun 6, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Veradermics Incorporated
- Grant date
- Expiration
- Claims
- 30
- CPC classes
- A61K, A61K2039/55555, A61K39/0002, A61K39/12, A61K39/35
More from Veradermics Incorporated
Related pharmaceutical patents in our USPTO index.
-
US 12403164
Lentiviral vector formulations
granted -
US 12403183
Factor VIII polypeptide formulations
granted -
US 12391750
Anti-C1S antibodies and methods of use thereof
granted -
US 12371747
Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
granted -
US 12364774
Nucleic acid molecules and uses thereof for non-viral gene therapy
granted -
US 12268688
Compositions and methods of use for modified release minoxidil
granted -
US 12257288
Methods of inducing immune tolerance to clotting factors
granted -
US 12240917
Anti-complement C1s antibodies and uses thereof
granted
Frequently asked questions
What is US patent 12005220?
US 12005220 (Microneedle patch for immunostimulatory drug delivery) is held by Veradermics Incorporated. Status: granted. Granted Jun 11, 2024. Expires Jun 6, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12005220?
Veradermics Incorporated is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 140 pharmaceutical patents for this assignee.
When does US 12005220 expire?
Our index shows an expiration date of Jun 6, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.